Curcumin C3 Reduct® (Tetrahydrocurcuminoids — Sabinsa)

Curcumin C3 Reduct® is a tetrahydrocurcuminoid (THC) ingredient from Sabinsa, the colorless metabolite form of turmeric's curcuminoids. Because the body normally converts curcumin into THC, delivering it pre-converted aims for better absorption and a strong, long-lasting antioxidant effect.

Curcumin C3 Reduct is researched primarily for Antioxidant and Anti-Inflammatory. Tetrahydrocurcuminoids are described as cascading antioxidants, providing strong and longer-lasting antioxidant activity than parent curcumin.

The clinically studied dose is Commonly around 150 to 600 mg per day. Always follow the product label and check with a healthcare provider for personal advice.

For most healthy adults, Curcumin C3 Reduct is well tolerated at studied doses. Reported effects can include: Generally well-tolerated — adverse effects are uncommon at normal doses. Mild digestive upset is occasionally reported. It may also interact with some medications. Curcumin C3 Reduct is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Possible interactions include: Anticoagulants — curcuminoids may have a mild additive effect; monitor. Gallbladder disease — use caution, as curcuminoids stimulate bile. If you take prescription medication, check with a pharmacist or doctor before using it.

NutraSmarts rates the evidence for Curcumin C3 Reduct as Limited (2 out of 5). It is backed by 1 clinical trial and 1 cited reference summarized on this page. A higher rating reflects more, larger, and better-designed human studies.